Page last updated: 2024-08-23

atomoxetine hydrochloride and Abnormalities, Congenital

atomoxetine hydrochloride has been researched along with Abnormalities, Congenital in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garcia-Bournissen, F; Humphreys, C; Ito, S; Koren, G1

Reviews

1 review(s) available for atomoxetine hydrochloride and Abnormalities, Congenital

ArticleYear
Exposure to attention deficit hyperactivity disorder medications during pregnancy.
    Canadian family physician Medecin de famille canadien, 2007, Volume: 53, Issue:7

    Topics: Abnormalities, Drug-Induced; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Congenital Abnormalities; Decision Making; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant, Newborn; Methylphenidate; Pregnancy; Pregnancy Complications; Propylamines; Risk Assessment

2007